PHARMAQ ANALYTIQ AS
PHARMAQ Analytiq applies targeted research and effective analyses with the aim of safeguarding fish health and welfare in the aquaculture sector
Organization
- CEO
- NA
- Chairman of the board
- NA
- Years since formation
- 25 years
- since Dec 18, 2000
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 57
Ownership
- Number of shares and share classes
- 11,000
- 1 share class
- Total number of shareholders
- 2
- 1 company, 1 person
Financials
- Total operating income 2024
- 88,568,844
- NOK
- Annual total result 2024
- -4,114,602
- NOK
- Total equity 2024
- 20,931,928
- NOK
Last update: Sep 13, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
NA | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
NA | Chairman | - |
BB 1975 | Deputy Chair | - |
TA | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 10,000 | 90.91 % | |
| Ordinary shares | 1,000 | 9.09 % |
Shares owned by the PHARMAQ ANALYTIQ AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 1,000 | 9.09 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 88,568,844 | 86,743,312 | 78,755,537 | 82,603,554 |
Annual Total Result | -4,114,602 | -536,577 | -4,847,241 | -2,989,021 |
Total assets | 45,796,940 | 40,398,097 | 50,285,253 | 57,211,840 |
Total liabilities | 24,865,012 | 20,072,378 | 29,422,956 | 36,955,940 |
Total equity | 20,931,928 | 20,325,719 | 20,862,297 | 20,255,900 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 88,568,844 | 86,743,312 | 78,755,537 | 82,603,554 |
Total operating costs | 93,166,087 | 86,769,906 | 84,654,011 | 86,234,596 |
Operating result | -4,597,243 | -26,594 | -5,898,474 | -3,631,042 |
Financial income/costs | -679,815 | -673,728 | -480,965 | -229,591 |
Profit before tax | -5,277,058 | -700,322 | -6,379,439 | -3,860,633 |
Total tax & extraordinary income/cost | -1,162,456 | -163,745 | -1,532,198 | -871,612 |
Annual Total Result | -4,114,602 | -536,577 | -4,847,241 | -2,989,021 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 19,762,666 | 21,525,375 | 23,521,895 | 26,919,159 |
Total current assets | 26,034,274 | 18,872,722 | 26,763,358 | 30,292,681 |
Total assets | 45,796,940 | 40,398,097 | 50,285,253 | 57,211,840 |
Short term debt | 24,475,351 | 19,851,772 | 29,001,736 | 36,540,727 |
Long term debt | 389,661 | 220,606 | 421,220 | 415,213 |
Total liabilities | 24,865,012 | 20,072,378 | 29,422,956 | 36,955,940 |
Contributed capital | 17,762,094 | 13,041,284 | 13,041,284 | 7,587,646 |
Retained earnings | 3,169,834 | 7,284,435 | 7,821,013 | 12,668,254 |
Total equity | 20,931,928 | 20,325,719 | 20,862,297 | 20,255,900 |
Total equity and liabilities | 45,796,940 | 40,398,097 | 50,285,253 | 57,211,840 |
Classification
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises